Clinical Trial Update: Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy, safety, and tolerability of neramexane in patients with tinnitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• Neramexane (neramexane)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Subjective Tinnitus | Phase 3 | Status: COMPLETED